Study S000445

Semaglutide in Patients With Type 2 Diabetes: Real-world Analysis in the Canadian LMC Diabetes Registry: The SPARE Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04175665
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 1133
Start: 2020-01-06
Primary completion: 2020-02-09
Lead sponsor: LMC Diabetes & Endocrinology Ltd.
Conditions: Type 2 Diabetes
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change in HbA1c [3 to 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.